Tsung-Min HUNG MD

Expert of Intensity-Modulated Proton Therapy (IMPT)

Esophageal cancer, Nasopharyneal carcinoma, Head and neck cancers

Specialty

Esophageal cancer, Nasopharyneal carcinoma, Head and neck cancers


Profile

Dr. Tsung-Min Hung obtained his degree of Doctor of Medicine at National Taiwan University School of Medicine and is now an attending physician in the department of radiation oncology at Linkou Chang Gung Memorial Hospital. In 2014-2015, Dr. Hung went to USA learning intensity-modulated proton therapy (IMPT) from Dr. Frank, the director of proton therapy center at MD Anderson Cancer Center.


Successful Cases

Dr. Hung treated over 100 new patients of every kind of cancer per year. However, each patient is an unique individual, and every person's condition and treatment details also have their unique characteristics. Dr. Hung, based on “listening and empathy" learned from Dr. Frank, fully discussed with the patients and their families to provide personalized precision medical treatment.

Education

National Taiwan University School of Medicine


Past Experiences

2014 - 2015, Visiting Scientist at MD Anderson Cancer Center in USA


Current Appointment

Attending Physician, Department of Radiation Oncology, Linkou Chang Gung Memorial Hospital

Major Publications

  1. Hung TM, Lin CR, Chi YC, Lin CY, Chen EY, Kang CJ, Huang SF, Juang YY, Huang CY*, Chang JT*. Body image in head and neck cancer patients treated with radiotherapy: the impact of surgical procedures. Health and Quality of Life Outcomes (2017) 15:165.(SCI)
  2. WK Yap, YC Chang, CK Tseng, CH Hsieh, YK Chao, PJ Su, MM Hou, CK Yang, PC Pai, CR Lin, CE Hsieh, YY Wu, TM Hung*. Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer. Diseases of the Esophagus (2017) 30, 1-10.(SCI)
  3. Hung TM, Fan KH, Chen EY, Lin CY, Kang CJ, Huang SF, Liao CT, Ng SH, Wang HM, Chang JT*. An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result. Medicine 2017;96(6):e6036.(SCI)
  4. Holliday EB, Garden AS, Rosenthal DI, Fuller CD, Morrison WH, Gunn GB, Phan J, Beadle BM, Zhu XR, Zhang X, Hanna E, Glisson BS, Hutcheson KA, El-Naggar AK, Hong JH, Hung TM, Uzel EK, Lewis G, Frank SJ*. Proton Therapy Reduces Treatment-Related Toxicities for Patients with Nasopharyngeal Cancer: A Case-Match Control Study of Intensity-Modulated Proton Therapy and Intensity-Modulated Photon Therapy. Int J Particle Ther 2015;2(1):19–28. 
  5. Hung TM, Chen CC, Lin CY, Ng SH, Kang CJ, Huang SF, Liao CT, Fan KH, Wang HM*, Chang JT*. Prognostic value of prepontine cistern invasion in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy. Oral Oncology 2014; 50: 228-233. (SCI)
  6. Hung TM, Wang HM, Kang CJ, Huang SF, Liao CT, Chan SC, Ng SH, Chen IH, Lin CY, Fan KH, Chang JT*. Pretreatment 18F-FDG PET standardized uptake value of primary tumor and neck lymph nodes as a predictor of distant metastasis for patients with nasopharyngeal carcinoma. Oral Oncology 2013; 49: 169-174. (SCI)